‌

US Patent 7560553 Use of fuse nicotinamides to promote neurogenesis

Patent 7560553 was granted and assigned to Neuralstem, Inc. on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Neuralstem, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7560553

Date of Patent

July 14, 2009

Patent Application Number

12049922

Date Filed

March 17, 2008

Patent Citations Received

‌

US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors

Patent Primary Examiner

‌

Janet L. Andres

Patent abstract

The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.